Tandem Diabetes (TNDM) Tops Q3 EPS by 15c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tandem Diabetes Care Reports Third Quarter 2015 Financial Results
October 29, 2015 4:06 PM EDTSAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4 Insulin Pumps, today reported its financial results for the quarter ended September 30, 2015.Â
In comparing the third quarter of 2015 to the same period of 2014:
Sales grew 16 percent to $15.7 million from $13.5 million Pump shipments grew 17 percent to 3,431 pumps from 2,935 pumps Operating margin improved to negative 119 percent from negative 141 percentIn comparing the nine months ended September 30, 2015 to the same period of... More
